Webinar – Risks of Using Exogenous Thyroid Hormone

IN THIS ISSUE: CLP 2025 Update | Committee Reports | SIG Reports | MAiD/PAS | Webinar | Emergency Behavioral Health

Risks of Using Exogenous Thyroid Hormone

Note the date now for March webinar

The March ACLP webinar is in association with the Integrative Medicine SIG and on the subject of Thyrotoxicosis Factitia: Psychiatric Manifestations of Exogenous Thyroid Use.

Wednesday, March 12, 12.30-1.00 PM EST

Michalla Braford, DO
Michalla Braford, DO

Trainee presenter is Michalla Braford, DO, PGY3 in Psychiatry, Lewis Gale Medical Center, Salem, and discussant is Claire Brandon, MD, founder and medical director of Whole Body Psychiatry in New York City.

Dr. Braford will present a clinical case that illuminates the risks of using exogenous thyroid hormone for wellness purposes and how this can translate to psychiatric symptoms.

Dr. Brandon will provide clinically relevant dialogue surrounding the risks of exogenous thyroid use and relevant laboratory and clinical findings in a provoked hyperthyroidism case.

The presentation and facilitated discussion will be followed by a live audience Q&A.

The session provides trainees with an opportunity to learn about C-L Psychiatry and augment C-L education at their institutions. Attendees will learn how to succinctly present a case, observe C-L psychiatrists work through diagnostic challenges, and appreciate management dilemmas that arise in C-L Psychiatry.

 

 

« All 2025 ACLP News« March 2025 ACLP News